Aehr Test Systems' Backlog Looks Bulletproof but the Timeline Doesn't

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

AEHR typically reports earnings after market close, meaning Day 0 reflects anticipation and positioning ahead of results, while Day +1 captures the market's first full reaction to the actual numbers.

AEHR exhibits extreme post-earnings volatility, with an average absolute Day +1 move of 21.23% — nearly six times the typical stock's earnings reaction. The most recent quarter (July 14, 2026) exemplifies this pattern: the stock surged 21.91% the day after reporting, following a 5.87% Day 0 gain, for a combined two-day move of over 27%. The prior three reports showed similar magnitude, with Day +1 moves of 25.69%, 15.95%, and -17.38%.

The direction of moves has been predominantly positive in recent quarters, with the stock rising the day after earnings in five of the last eight reports. However, the -17.38% plunge following the October 2025 miss (when AEHR reported -$0.05 versus -$0.03 estimated) demonstrates the downside risk when the company disappoints. The average Day 0 move of 3.66% is relatively modest compared to the Day +1 reaction, consistent with after-hours reporting where the market's full response materializes the following session.

Investors should prepare for significant price swings regardless of direction — even modest beats or misses have historically triggered double-digit percentage moves in this thinly traded, high-beta semiconductor equipment name.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of ±9.31% through October 9 expiration, implying a range of roughly $96.88 to $116.77 from the current $106.82. This is substantially below AEHR's historical average Day +1 move of 21.23%, suggesting options are underpricing the potential volatility. The 96.63% implied volatility is elevated in absolute terms but appears conservative given AEHR's track record of delivering moves exceeding 15% in six of the last eight reports.

Part 3: What Analysts Are Saying

Analysts maintain a strongly bullish stance on AEHR heading into earnings, with the consensus rating at 4.71 out of 5.00 (between Buy and Strong Buy). The current breakdown shows 6 Strong Buys, 0 Moderate Buys, 1 Hold, 0 Moderate Sells, and 0 Strong Sells across 7 analysts covering the stock. However, sentiment has deteriorated slightly from a month ago, when the average recommendation stood at a perfect 5.00 with 6 Strong Buys and no Hold ratings — the recent addition of a single Hold rating pulled the consensus down modestly.

The average price target of $128.00 implies 19.4% upside from the current price of $107.21, with estimates ranging from a low of $110.00 (+2.6%) to a high of $175.00 (+63.2%). The wide target range reflects differing views on how quickly AEHR can scale revenue and achieve the profitability margins management has guided for fiscal 2027. The $128 mean target sits roughly in the middle of management's $130M–$150M revenue guidance range, suggesting analysts are modeling toward the midpoint of the outlook rather than assuming upside scenarios.

The slight deterioration in sentiment — from unanimous Strong Buys to the addition of one Hold — likely reflects valuation concerns after the stock's 54% year-to-date rally rather than fundamental doubts about the business trajectory. With shares trading at a forward P/E above 200x and near 52-week highs, at least one analyst appears to be taking a more cautious stance on risk/reward heading into what could be a volatile earnings event.

Part 4: Technical Picture

AEHR enters earnings with strong technical momentum across all timeframes. The Barchart Technical Opinion currently stands at 88% Buy, up sharply from 72% Buy a week ago and 32% Buy a month ago, indicating rapidly improving sentiment as the stock has rallied into the release.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal suggests near-term momentum is positive but not extreme, leaving room for further upside if earnings deliver
• Medium-term (100% Buy): Strong buy signal indicates solid intermediate-term trend support with no signs of exhaustion
• Long-term (100% Buy): Strong buy signal reflects a well-established uptrend over the longer timeframe, consistent with the stock's 54% year-to-date gain

Trend Characteristics: The trend is characterized as Average strength but moving in the Strongest direction, suggesting momentum is accelerating even if the underlying trend structure remains moderate — a setup that can produce sharp moves in either direction around catalysts like earnings.

The stock is trading above all key moving averages, including the 5-day ($101.54), 10-day ($100.44), 20-day ($94.94), 50-day ($96.19), 100-day ($94.88), and 200-day ($69.62). This clean alignment with the current price of $107.21 sitting 6–7% above even the shortest-term averages confirms the strength of the recent rally.

The 200-day moving average at $69.62 — roughly 35% below current levels — illustrates how far and fast AEHR has run in 2026, while the tight clustering of shorter-term averages in the $95–$102 range provides a well-defined support zone should the stock pull back post-earnings. The technical setup is supportive heading into the release, with momentum, trend alignment, and improving sentiment all pointing higher. However, the magnitude of the recent rally and the stock's history of extreme post-earnings volatility mean a disappointment could trigger a sharp reversal, with the 20-day moving average around $95 representing the first meaningful support level.